Strategic Partnerships Longenesis collaborates with leading healthcare institutions, global life sciences companies, and governments, indicating a strong openness to enterprise partnerships. This presents a sales opportunity to offer comprehensive data collaboration, patient engagement, and consent management solutions to large health systems and cross-border projects.

Health Data Platform The company provides digital tools for patient cohort discovery, engagement, and consent management, suggesting potential upsell to expand data capture, analytics capabilities, and compliant data sharing across life sciences trials, registries, and real-world evidence programs.

EU MENA Focus Impact across EU and Middle East and North Africa regions with prior patient reach of over 700,000 implies readiness to scale regionally. Sales efforts can target regional health authorities, hospitals, and biopharma needing interoperable digital health data platforms in these markets.

Industry Recognition Awards including Riga Startup of the Year and AWS Special Award bolster credibility with potential customers and investors. Use these differentiators in outreach to enterprise buyers seeking validated innovative vendors with cloud and AI-friendly capabilities.

Financial Context Revenue range of 50 to 100 million with modest funding signals a mature, revenue-generating startup. Opportunities exist to propose scalable deployment contracts, enterprise licensing, and expansion deals with long-term renewals that align with customer adoption growth.